PL2150253T3 - Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego - Google Patents

Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Info

Publication number: PL2150253T3
Authority: PL; Poland
Prior art keywords: oxydopyridin; cyclopropylmethoxy; carboxamide; dichloro; pyridine
Prior art date: 2007-04-19

Application number

PL08787962T

Other languages

English (en)

Inventor

Philippe Delay-Goyet

Badia Ferzaz

Jocelyne Lolivier

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-19

Filing date

2008-04-16

Publication date

2011-08-31

2008-04-16 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2011-08-31 Publication of PL2150253T3 publication Critical patent/PL2150253T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

PL08787962T 2007-04-19 2008-04-16 Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego PL2150253T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0702851A FR2915098B1 (fr)	2007-04-19	2007-04-19	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
PCT/FR2008/000533 WO2008145840A2 (fr)	2007-04-19	2008-04-16	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
EP08787962A EP2150253B1 (fr)	2007-04-19	2008-04-16	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Publications (1)

Publication Number	Publication Date
PL2150253T3 true PL2150253T3 (pl)	2011-08-31

Family

ID=38779706

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08787962T PL2150253T3 (pl)	2007-04-19	2008-04-16	Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Country Status (33)

Country	Link
US (1)	US8592443B2 (pl)
EP (1)	EP2150253B1 (pl)
JP (1)	JP5386477B2 (pl)
KR (1)	KR101470043B1 (pl)
CN (1)	CN101674829B (pl)
AR (1)	AR066106A1 (pl)
AT (1)	ATE503481T1 (pl)
AU (1)	AU2008257321B2 (pl)
BR (1)	BRPI0810446A2 (pl)
CA (1)	CA2684172C (pl)
CL (1)	CL2008001134A1 (pl)
CY (1)	CY1111779T1 (pl)
DE (1)	DE602008005873D1 (pl)
DK (1)	DK2150253T3 (pl)
EA (1)	EA015355B1 (pl)
ES (1)	ES2363056T3 (pl)
FR (1)	FR2915098B1 (pl)
HR (1)	HRP20110459T1 (pl)
IL (1)	IL201451A (pl)
JO (1)	JO2662B1 (pl)
MA (1)	MA31369B1 (pl)
ME (1)	ME00934B (pl)
MX (1)	MX2009011285A (pl)
MY (1)	MY146657A (pl)
NZ (1)	NZ580483A (pl)
PA (1)	PA8776601A1 (pl)
PL (1)	PL2150253T3 (pl)
PT (1)	PT2150253E (pl)
PY (1)	PY08013253A (pl)
SI (1)	SI2150253T1 (pl)
TW (1)	TWI411435B (pl)
UY (1)	UY31033A1 (pl)
WO (1)	WO2008145840A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2915099B1 (fr)	2007-04-19	2009-06-05	Sanofi Aventis Sa	Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
SG11201503766SA (en) *	2012-11-28	2015-06-29	Sanofi Sa	Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
MX2015006807A (es) *	2012-11-28	2016-01-14	Sanofi Sa	Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.
EP4281065A1 (en)	2021-01-20	2023-11-29	Alto Neuroscience, Inc.	Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions
CN122055155A (zh) *	2023-10-12	2026-05-15	美德阿利克斯株式会社	经皮吸收组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4193926A (en)	1974-03-20	1980-03-18	Schering Aktiengesellschaft	4-(Polyalkoxy phenyl)-2-pyrrolidones
ZA945609B (en)	1993-07-28	1995-05-12	Rhone Poulenc Rorer Ltd	[Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
GB9401460D0 (en)	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
GB9507297D0 (en)	1995-04-07	1995-05-31	Rh Ne Poulenc Rorer Limited	New composition of matter
US6196968B1 (en)	1997-06-02	2001-03-06	General Surgical Innovations, Inc.	Direct vision subcutaneous tissue retractor and method for use
US6177077B1 (en) *	1999-02-24	2001-01-23	Edward L. Tobinick	TNT inhibitors for the treatment of neurological disorders
DE60018470T2 (de) *	1999-12-23	2006-02-16	Icos Corp., Bothell	Cyclische amp spezifische phosphodiesterase inhibitoren
US20030069169A1 (en)	2001-03-02	2003-04-10	Macor John E.	Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
US20060004056A1 (en)	2002-07-02	2006-01-05	Bernard Cote	Di-aryl-substituted-ethan pyridone pde4 inhibitors
US20060083714A1 (en)	2003-01-27	2006-04-20	Warner James M	Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2005034870A2 (en) *	2003-10-07	2005-04-21	Renovis, Inc.	Amide compounds and ion channel ligands and uses thereof
US20070049611A1 (en) *	2005-06-10	2007-03-01	Talamas Francisco X	Phosphodiesterase 4 inhibitors
US20070021451A1 (en) *	2005-07-20	2007-01-25	Hamamatsu University School Of Medicine	Method for preventing or treating neurologic damage after spinal cord injury

2007
- 2007-04-19 FR FR0702851A patent/FR2915098B1/fr not_active Expired - Fee Related
2008
- 2008-04-15 PA PA20088776601A patent/PA8776601A1/es unknown
- 2008-04-16 CA CA2684172A patent/CA2684172C/fr not_active Expired - Fee Related
- 2008-04-16 AT AT08787962T patent/ATE503481T1/de active
- 2008-04-16 PL PL08787962T patent/PL2150253T3/pl unknown
- 2008-04-16 DE DE602008005873T patent/DE602008005873D1/de active Active
- 2008-04-16 EA EA200970969A patent/EA015355B1/ru not_active IP Right Cessation
- 2008-04-16 ME MEP-2009-298A patent/ME00934B/me unknown
- 2008-04-16 DK DK08787962.3T patent/DK2150253T3/da active
- 2008-04-16 AU AU2008257321A patent/AU2008257321B2/en not_active Ceased
- 2008-04-16 CN CN2008800125419A patent/CN101674829B/zh not_active Expired - Fee Related
- 2008-04-16 KR KR1020097021624A patent/KR101470043B1/ko not_active Expired - Fee Related
- 2008-04-16 EP EP08787962A patent/EP2150253B1/fr active Active
- 2008-04-16 SI SI200830270T patent/SI2150253T1/sl unknown
- 2008-04-16 ES ES08787962T patent/ES2363056T3/es active Active
- 2008-04-16 MX MX2009011285A patent/MX2009011285A/es active IP Right Grant
- 2008-04-16 PT PT08787962T patent/PT2150253E/pt unknown
- 2008-04-16 WO PCT/FR2008/000533 patent/WO2008145840A2/fr not_active Ceased
- 2008-04-16 NZ NZ580483A patent/NZ580483A/en not_active IP Right Cessation
- 2008-04-16 HR HR20110459T patent/HRP20110459T1/hr unknown
- 2008-04-16 JP JP2010503548A patent/JP5386477B2/ja not_active Expired - Fee Related
- 2008-04-16 MY MYPI20094338A patent/MY146657A/en unknown
- 2008-04-16 BR BRPI0810446-8A2A patent/BRPI0810446A2/pt not_active IP Right Cessation
- 2008-04-17 TW TW097114000A patent/TWI411435B/zh not_active IP Right Cessation
- 2008-04-17 JO JO2008185A patent/JO2662B1/en active
- 2008-04-18 CL CL2008001134A patent/CL2008001134A1/es unknown
- 2008-04-18 AR ARP080101600A patent/AR066106A1/es unknown
- 2008-04-18 UY UY31033A patent/UY31033A1/es not_active Application Discontinuation
- 2008-04-18 PY PY200808013253A patent/PY08013253A/es unknown
2009
- 2009-10-05 US US12/573,316 patent/US8592443B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201451A patent/IL201451A/en not_active IP Right Cessation
- 2009-11-10 MA MA32335A patent/MA31369B1/fr unknown
2011
- 2011-06-28 CY CY20111100611T patent/CY1111779T1/el unknown

Also Published As

Publication number	Publication date
ME00934B (me)	2012-06-20
IL201451A (en)	2013-04-30
MX2009011285A (es)	2009-11-02
HK1142000A1 (en)	2010-11-26
US20100137370A1 (en)	2010-06-03
US8592443B2 (en)	2013-11-26
DK2150253T3 (da)	2011-07-25
TW200911248A (en)	2009-03-16
WO2008145840A3 (fr)	2009-06-25
EA200970969A1 (ru)	2010-02-26
NZ580483A (en)	2011-06-30
CL2008001134A1 (es)	2009-01-16
WO2008145840A2 (fr)	2008-12-04
TWI411435B (zh)	2013-10-11
AU2008257321B2 (en)	2013-08-15
SI2150253T1 (sl)	2011-07-29
CN101674829A (zh)	2010-03-17
MA31369B1 (fr)	2010-05-03
CA2684172A1 (fr)	2008-12-04
DE602008005873D1 (de)	2011-05-12
KR101470043B1 (ko)	2014-12-05
JP2010524905A (ja)	2010-07-22
EA015355B1 (ru)	2011-06-30
EP2150253A2 (fr)	2010-02-10
PY08013253A (es)	2013-08-01
PA8776601A1 (es)	2008-11-19
CY1111779T1 (el)	2015-10-07
JO2662B1 (en)	2012-06-17
KR20090130063A (ko)	2009-12-17
AR066106A1 (es)	2009-07-22
AU2008257321A1 (en)	2008-12-04
PT2150253E (pt)	2011-06-17
UY31033A1 (es)	2008-11-28
ES2363056T3 (es)	2011-07-19
MY146657A (en)	2012-09-14
FR2915098B1 (fr)	2009-06-05
EP2150253B1 (fr)	2011-03-30
CA2684172C (fr)	2015-10-27
BRPI0810446A2 (pt)	2014-10-14
HRP20110459T1 (hr)	2011-07-31
ATE503481T1 (de)	2011-04-15
CN101674829B (zh)	2012-01-18
IL201451A0 (en)	2010-05-31
JP5386477B2 (ja)	2014-01-15
FR2915098A1 (fr)	2008-10-24

Publication	Publication Date	Title
EP1854415A4 (en)	2015-01-21	SURGICAL TREATMENT DEVICE
EP1874259A4 (en)	2016-03-23	TREATMENT DEVICE FOR KNEES TRACKING
BRPI0808246A2 (pt)	2018-10-30	"fralda descartável".
IL184710A0 (en)	2007-12-03	1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
EP2116255A4 (en)	2011-05-04	MEANS FOR THE TREATMENT OF BACKBREAK INJURIES
ITMI20072397A1 (it)	2009-06-21	Apparecchiatura medicale per il trattamento extracorporeo
IL206657A0 (en)	2010-12-30	Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
DK2150253T3 (da)	2011-07-25	Anvendelse af 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridin-2-carboxamid til behandling af rygmarvsskader
ZA201005306B (en)	2011-04-28	5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
PT2146714E (pt)	2011-09-02	Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxidopiridin- 4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento dos distúrbios motores relacionados com a doença de parkinson
PL2129373T3 (pl)	2013-10-31	Zastosowanie genisteiny do leczenia zespołu suchego oka
PL2146713T3 (pl)	2012-04-30	Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksyamidu do leczenia urazów mózgowych
GB0710277D0 (en)	2007-07-11	Use of antivirals in the treatment of medical disorders
GB0721616D0 (en)	2007-12-12	Treatment of spinal cord injury
TH0801001896A (th)	2015-06-12	การใช้ 4-ไซโคลโพรพิลเมธอกซิ-n-(3,5-ไดคลอโร-1-ออกซิโด-ไพริดิน-4-อิล)-5-(เมธอกซิ)ไพริดีน-2-คาร์บอกซามีด ในการรักษาการบาดเจ็บไขสันหลัง
FI20075143A0 (fi)	2007-02-27	Laite potilaan lämmittämiseksi
ES1067907Y (es)	2008-10-16	Aparato gimnastico de abdominales extensible apto para usar en la cama o cualquier otra superficie.
GB0704664D0 (en)	2007-04-18	Treatment device 3
GB0704662D0 (en)	2007-04-18	Treatment device 2
GB0700886D0 (en)	2007-02-21	Medical treatment
SE0400576D0 (sv)	2004-03-05	A novel pharmacentical composition for the treatment of spinal cord injury